REG - CVS Group plc - Exercise of Options, PDMR Dealing and TVR

CVSAnnouncement

04/01/2022 07:01

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220104:nRSD0520Xa&default-theme=true

RNS Number : 0520X  CVS Group plc  04 January 2022

4 January 2022

 

CVS Group Plc

("CVS", the "Company" or the "Group")

Exercise of Options, PDMR Dealing and Total Voting Rights

CVS, one of the UK's leading providers of integrated veterinary services,
announces that on 4 January 2022, options over a total of 63,320 new ordinary
shares of 0.2 pence each (the "New Shares") were exercised under the CVS Group
2018 SAYE Plan (2018/2021), at an exercise price of £8.30.

Richard Fairman, Chief Executive Officer, and Ben Jacklin, Chief Operating
Officer, each exercised options over 737 ordinary shares of 0.2p in the
Company ("Ordinary Shares").  The balance of the options were exercised by
certain other employees and former employees of the Company.

Following their respective option exercises, Richard Fairman holds a
beneficial interest in 29,462 Ordinary Shares in the Company, representing
approximately 0.042 per cent of the total voting rights of the Company
following the issue of the New  Shares, and Ben Jacklin holds a beneficial
interest in 5,446 Ordinary Shares in the Company, representing approximately
0.008 per cent of the total voting rights of the Company, calculated on the
same basis.

Following the issue of the New Shares, the Company has a total issued share
capital of 70,934,113 Ordinary Shares each carrying one voting right. The
Company holds no Ordinary Shares in treasury. Therefore, following the issue
of the New Shares, the total number of voting rights in the Company will be
70,934,113. This figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under the FCA's
Disclosure Guidance and Transparency Rules.

The notification below, made in accordance with the requirements of the UK
Market Abuse Regulation, provides further detail.

This announcement is released by CVS Group plc and contains inside information
for the purposes of the retained UK version of the EU Market Abuse Regulation
(EU) 596/2014 ("UK MAR"), encompassing information relating to trading for the
Company's current financial year, and is disclosed in accordance with the
Company's obligations under UK MAR. This announcement is being made on behalf
of the Company by the director named below.

 

Contacts:

 CVS Group plc                                            via MHP Communications
 Richard Fairman, CEO
 Jenny Farrer, Company Secretary
 Singer Capital Markets (Nominated Adviser & Broker)      +44 20 7496 3000
 Aubrey Powell / Jen Boorer / Rachel Hayes
 MHP Communications (Financial PR)                        +44 20 3128 8549
 Andrew Jaques / Rachel Mann / Charles Hirst

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 1   Details of the person discharging managerial responsibilities / person closely
     associated
 a)  Name                                      Richard Fairman
 2   Reason for the notification
 a)  Position/status                           Chief Executive Officer
 b)  Initial notification /Amendment           Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                      CVS Group plc
 b)  LEI                                       213800J41XDQ2NX48O05
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted

 

 a)  Description of the financial instrument, type of instrument  Ordinary shares of 0.2 pence each

     Identification code                                          GB00B2863827
 b)  Nature of the transaction                                    Exercise of options under the 2018 SAYE Plan (1 January   2022 maturity)

 c)  Price(s) and volume(s)
 d)  Aggregated information

     - Aggregated volume

                                                                  N/A - single transaction

     - Price
 e)  Date of the transaction                                      4 January 2022
 f)  Place of the transaction                                     London Stock Exchange

 

 

 1   Details of the person discharging managerial responsibilities / person closely
     associated
 a)  Name                                                         Ben Jacklin

 2   Reason for the notification
 a)  Position/status                                              Chief Operating Officer
 b)  Initial notification /Amendment                              Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         CVS Group plc
 b)  LEI                                                          213800J41XDQ2NX48O05
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of 0.2 pence each

     Identification code                                          GB00B2863827
 b)  Nature of the transaction                                     Exercise of options under the 2018 SAYE Plan (1 January 2022 maturity)
 c)  Price(s) and volume(s)
                                                                                       Price(s)             Volume(s)
       £8.30                                                                           737

 d)  Aggregated information

     - Aggregated volume

                               N/A - single transaction

     - Price
 e)  Date of the transaction   4 January 2022
 f)  Place of the transaction  London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEKBLBXFLLZFBF